Qiagen Nv Stock Current Valuation
| QIA Stock | EUR 43.86 0.19 0.44% |
Valuation analysis of QIAGEN NV helps investors to measure QIAGEN NV's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that QIAGEN NV's price fluctuation is very steady at this time. Calculation of the real value of QIAGEN NV is based on 3 months time horizon. Increasing QIAGEN NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the QIAGEN stock is determined by what a typical buyer is willing to pay for full or partial control of QIAGEN NV. Since QIAGEN NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of QIAGEN Stock. However, QIAGEN NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 43.86 | Real 42.53 | Hype 43.86 |
The real value of QIAGEN Stock, also known as its intrinsic value, is the underlying worth of QIAGEN NV Company, which is reflected in its stock price. It is based on QIAGEN NV's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of QIAGEN NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of QIAGEN NV helps investors to forecast how QIAGEN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of QIAGEN NV more accurately as focusing exclusively on QIAGEN NV's fundamentals will not take into account other important factors: QIAGEN NV Company Current Valuation Analysis
QIAGEN NV's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current QIAGEN NV Current Valuation | 11.01 B |
Most of QIAGEN NV's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, QIAGEN NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, QIAGEN NV has a Current Valuation of 11.01 B. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The current valuation for all Germany stocks is notably lower than that of the firm.
QIAGEN Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses QIAGEN NV's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of QIAGEN NV could also be used in its relative valuation, which is a method of valuing QIAGEN NV by comparing valuation metrics of similar companies.QIAGEN NV is currently under evaluation in current valuation category among its peers.
QIAGEN Fundamentals
| Current Valuation | 11.01 B | |||
| Price To Book | 3.38 X | |||
| Price To Sales | 5.11 X | |||
| Revenue | 2.14 B | |||
| EBITDA | 779.36 M | |||
| Net Income | 423.21 M | |||
| Total Debt | 1.47 B | |||
| Cash Flow From Operations | 715.26 M | |||
| Price To Earnings To Growth | 8.39 X | |||
| Number Of Employees | 22 | |||
| Market Capitalization | 10.94 B | |||
| Total Asset | 6.29 B | |||
| Z Score | 4.2 | |||
| Net Asset | 6.29 B |
About QIAGEN NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze QIAGEN NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QIAGEN NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QIAGEN NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in QIAGEN Stock
When determining whether QIAGEN NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of QIAGEN NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in QIAGEN NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade QIAGEN Stock refer to our How to Trade QIAGEN Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.